Evidence map›Paper›PMID 40382628›Full record

ArticleJournal of health, population, and nutrition2025

Serum zinc concentration and history of isCGM contact dermatitis in type 1 diabetes.

Mitsunobu Kubota, Shizuka Matsuda, Mimu Matsuda, Shinji Maeda, Sayo Yoshiyama

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mitsunobu KubotaDepartment of Endocrinology and Diabetology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyamacho, Kure, Hiroshima, 737-0023, Japan. takubonx@kba.biglobe.ne.jp.
Shizuka MatsudaDepartment of Endocrinology and Diabetology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyamacho, Kure, Hiroshima, 737-0023, Japan.
Mimu MatsudaDepartment of Endocrinology and Diabetology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyamacho, Kure, Hiroshima, 737-0023, Japan.
Shinji MaedaDepartment of Endocrinology and Diabetology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyamacho, Kure, Hiroshima, 737-0023, Japan.
Sayo YoshiyamaDepartment of Endocrinology and Diabetology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyamacho, Kure, Hiroshima, 737-0023, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn insulin treatment for type 1 diabetes, intermittent scanning continuous glucose monitoring (isCGM: FreeStyle® Libre), in which a sensor is adhered to the skin, is often used to monitor blood glucose fluctuations and manage glucose levels. Zinc-deficient skin is reportedly more susceptible to primary irritant rashes. This study investigated whether zinc deficiency is associated with a history of contact dermatitis caused by isCGM in patients with type 1 diabetes.

methodsThe subjects comprised 55 patients (23 men, 32 women, age 57.9 ± 17.6 years) with type 1 diabetes who were outpatients at our department and had a history of isCGM use. We examined the history of contact dermatitis due to isCGM in relation to serum zinc concentration.

resultsSerum zinc was significantly lower in those with history of contact dermatitis (23 subjects) compared to those without (32 subjects) (P = 0.033). History of contact dermatitis due to isCGM was negatively associated with both age (β =  - 0.266, P = 0.040) and zinc deficiency category (β =  - 0.315, P = 0.017).

conclusionsFor people undergoing treatment for type 1 diabetes for whom skin problems caused by isCGM are a barrier to glucose management, screening of serum zinc concentration may be important.

Indexed as

Blood Glucose Self-MonitoringDermatitis, ContactDiabetes Mellitus, Type 1ZincAdultAgedBlood GlucoseFemaleHumansInsulinMaleMiddle AgedBlood GlucoseInsulinZincContact dermatitisIntermittent scanning continuous glucose monitorSerum zinc concentrationType 1 diabetes

Identifiers

PMID40382628
PMCPMC12084942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.